Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-155P is a predicted pseudogene, classified by sequence similarity to U6 small nuclear RNA, a non-coding RNA essential for the spliceosome's reaction in excising introns from pre-mRNA[1]. U6 snRNAs are highly conserved and produce many pseudogene copies in vertebrate genomes, which are largely non-functional and do not code for proteins or active RNAs[1]. There are no known biological, pharmacological, or clinical roles for RNU6-155P. Functional U6 snRNA participates in post-transcriptional mRNA splicing in eukaryotes, but RNU6-155P has not been shown to fulfill this role, nor is there evidence of involvement in disease, drug interactions, or clinical biomarker applications[1][2][4][6]. Summary: RNU6-155P is a pseudogene with no documented biological, pharmacological, or clinical relevance. It is not a functional receptor, enzyme, transporter, or therapeutic target, and should not be confused with active components of the spliceosome like U6 snRNA[1][2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 155, pseudogene (RNU6-155P).